Volume 2 Issue 4 | April 2007
The pace of change and growth in the pharmaceutical and biotech environment means that most companies face the daunting task of relocating laboratories at some stage in their development.
A review of some papers presented at the eleventh annual conference on product development metrics.
Once in my early days as a bench chemist, lab notebooks were collected to serve as evidence in a patent law suit. This experience put the fear into me. I learned a lesson in all aspects of documentation and in reporting defensible data.
Although only recently identified as a new class of molecules, microRNAs have emerged as a one of the most promising areas of research today. Recent data further suggest that medical conditions, such as cancer, can be associated with specific microRN